Chloramphenicol topical treatment and agranulocytosis
- the evidence of a causal relationship between the use of topical chloramphenicol and agranulocytosis is not compelling (1,2)
Reference:
- (1) Doon M, Walsh JB (1995). Use of chloramphenicol as a topical eye medication, time to cry a halt?. BMJ, 310, 12178.
- (2) Walker S et al (1998). Lack of evidence of toxicity following topical chloramphenicol use. Eye, 12, 8759.
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.